Correlation Between Salesforce and Invesco Nasdaq

Can any of the company-specific risk be diversified away by investing in both Salesforce and Invesco Nasdaq at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Invesco Nasdaq into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Salesforce and Invesco Nasdaq Biotechnology, you can compare the effects of market volatilities on Salesforce and Invesco Nasdaq and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Invesco Nasdaq. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Invesco Nasdaq.

Diversification Opportunities for Salesforce and Invesco Nasdaq

-0.58

Correlation Coefficient

Salesforce  Invesco Nasdaq

Excellent diversification

The 3 months correlation between Salesforce and Invesco is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Invesco Nasdaq Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Invesco Nasdaq Biote and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Invesco Nasdaq. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Invesco Nasdaq Biote has no effect on the direction of Salesforce i.e., Salesforce and Invesco Nasdaq go up and down completely randomly.

Pair Corralation between Salesforce and Invesco Nasdaq

Considering the 90-day investment horizon Salesforce is expected to generate 1.9 times more return on investment than Invesco Nasdaq. However, Salesforce is 1.9 times more volatile than Invesco Nasdaq Biotechnology. It trades about 0.09 of its potential returns per unit of risk. Invesco Nasdaq Biotechnology is currently generating about 0.01 per unit of risk. If you would invest  14,464  in Salesforce on October 9, 2024 and sell it today you would earn a total of  18,589  from holding Salesforce or generate 128.52% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	99.8%
Values	Daily Returns

Salesforce  vs.  Invesco Nasdaq Biotechnology

Salesforce

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Salesforce are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Salesforce displayed solid returns over the last few months and may actually be approaching a breakup point.

Invesco Nasdaq Biote

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Invesco Nasdaq Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Etf's fundamental drivers remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the ETF retail investors.

Pair Trading with Salesforce and Invesco Nasdaq

The main advantage of trading using opposite Salesforce and Invesco Nasdaq positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Invesco Nasdaq can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Invesco Nasdaq will offset losses from the drop in Invesco Nasdaq's long position.

The idea behind Salesforce and Invesco Nasdaq Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.